Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Yestar Healthcare Holdings Co Ltd ( (HK:2393) ) just unveiled an update.
Yestar Healthcare Holdings Co Ltd has announced plans to form a joint venture in Singapore with New Genetron Holding Limited, focusing on establishing clinical molecular diagnostics laboratories in Indonesia. The venture aims to advance precision oncology by offering services like early cancer screening and comprehensive genomic profiling, leveraging Genetron Health’s technology. This strategic move is expected to enhance Yestar’s market presence in Southeast Asia and foster partnerships with Indonesian healthcare institutions, potentially impacting the company’s operational scope and industry positioning.
More about Yestar Healthcare Holdings Co Ltd
Yestar Healthcare Holdings Co Ltd is primarily engaged in the distribution of in vitro diagnostic (IVD) products in the cities of the People’s Republic of China (PRC). The company also manufactures medical films for imaging technologies such as X-Ray, MRI, and CT-scan for Fujifilm in the PRC, and produces dental film and medical dry film products under its own brand ‘Yes!Star’.
Average Trading Volume: 4,996,847
Technical Sentiment Signal: Hold
Current Market Cap: HK$295.9M
See more data about 2393 stock on TipRanks’ Stock Analysis page.